Matthew Kalnik
Overview
Matthew Kalnik received $359K in total compensation at Neuralstem in 2019. Matthew Kalnik also received an average of $932K at Biota Pharmaceuticals from 2010 to 2012.
- 2019
- 2012
- 2011
- 2010
NeuralstemChief Operating Officer and President
Biota PharmaceuticalsFormer Sr. Vice President, Strategic Planning & Business Operations
Biota PharmaceuticalsFormer Sr. Vice President, Strategic Planning & Business Operations
Biota PharmaceuticalsFormer Sr. Vice President, Strategic Planning & Business Operations
Source: SEC filings on June 24, 2020 and October 1, 2013.
Related executives
We found 27 more executives who work or worked at Neuralstem and Biota Pharmaceuticals.
Andrei Floroiu
Biota Pharmaceuticals
Chief Executive Officer
James Cummings
Biota Pharmaceuticals
Chief Medical Officer
Sean Tucker
Biota Pharmaceuticals
Chief Scientific Officer
Wouter Latour
Biota Pharmaceuticals
Chief Executive Officer
Margaret Echerd
Biota Pharmaceuticals
SVP Controller and Principal Accounting Officer
Kenneth Carter
Neuralstem
Chairman
Dane Saglio
Neuralstem
Chief Financial Officer
Joseph Patti
Biota Pharmaceuticals